Featured New Book Titles, 10/25/07

Brain Metastases / edited by Jeffrey J. Raizer, Lauren E. Abrey. New York : Springer , c2007.

New Book Shelf | WL358 B7325 2007

Review: "Brain metastases are one of the most devasting consequences of cancer. This text addresses the epidemiology, pathophysiology, imaging, and management of this complication. Experts in the field cover a broad array of relevant topics highlighting the challenges and current therapeutic strategies."

Steven T. Rosen, M.D. Series Editor

Essentials of Psychosomatic Medicine / edited by James L. Levenson. Washington, DC : American Psychiatric Pub., c2007.

New Book Shelf | WM90 Es74 2007

Book Description (Amazon): This condensed version of The American Psychiatric Publishing Textbook of Psychosomatic Medicine focuses on psychiatric care for medically ill patients. Essentials of Psychosomatic Medicine presents that portion of the larger work devoted to specific disorders, enabling the practitioner to assist patients with comorbid psychiatric and general medical illnesses complicating each other's management. Each chapter covers epidemiology, psychological factors affecting specific diseases, the effects those diseases have on mental health, diagnostic issues, and treatment, including psychotherapy, psychopharmacology, psychiatric side effects of drugs for medical conditions, and drug interactions relevant to the diseases covered. More succinct than the Textbook while offering broader coverage than most other books on psychiatric care of medical patients, Essentials first guides users through general principles in evaluation and management and then offers, in concise form, all 18 specialty chapters from the Textbook, updated for this edition. All of the medical specialties are covered, including the internal medicine subspecialties, neurology, surgery, ob-gyn, organ transplantation, pediatrics, dermatology, physical medicine, and pain management. Each chapter ends with multiple-choice questions for self-assessment. Among the range of issues taken up are

• Depression as a major factor affecting medical outcomes in coronary artery disease, diabetes, and other diseases.
• Neuropsychiatric presentations of endocrine, rheumatologic, and infectious diseases.
• Controversies surrounding functional disorders like irritable bowel syndrome, fibromyalgia, and chronic fatigue syndrome.
• Psychiatric complications of medical treatments like chemotherapy, implanted defibrillators, and immunosuppression.
• Psychological factors affecting medical compliance and surgical results.
• Special considerations in using psychiatric drugs in the medically ill

Managing Metabolic Abnormalities in the Psychiatrically Ill : a Clinical Guide for Psychiatrists / edited by Richard A. Bermudes, Paul E. Keck Jr., Susan L. McElroy. Washington, DC : American Psychiatric Pub., c2007.

New Book Shelf | WM140 M312 2007

Book Description (Amazon): Patients with mental and substance use disorders have shown higher rates of morbidity and mortality from medical illnesses than the general population, and physicians are also increasingly aware of adverse effects of psychiatric medications on metabolic and cardiovascular health. In light of these problems, this book addresses an important unmet need of patients with mental disorders--namely, the lack of integration of general medical care with psychiatric care and the related problem of barriers to collaboration and communication among health care providers. Managing Metabolic Abnormalities in the Psychiatrically Ill is the first book to provide a current review of the relationships among psychiatric illnesses, metabolic abnormalities, and treatment, focusing on how clinicians can tailor care to those doubly-afflicted patients.

The book integrates research findings into practical clinical guidelines that spell out what psychiatrists need to know when their patients with mental illness suffer from--or are at risk of developing--obesity, diabetes, cardiovascular disease, or the metabolic syndrome. The contributors address those risks that need to be considered in the overall context of treatment, background risks of medical illnesses associated with specific psychiatric disorders themselves, and the means of applying these data to treatment recommendations, monitoring, and clinical practice. Among the specific topics addressed are:

• Potential effects of psychotropics on appetite, body weight, and metabolic parameters in obese patients, and the potential effects of anti-obesity agents on psychotic, manic, and depressive syndromes
• Increased risk of type 2 diabetes among individuals with psychotic and mood disorders due to neurobiological changes and behavioral effects associated with these disorders
• Greater risk for cardiovascular disease among the mentally ill, stressing the importance of mental health providers understanding cardiovascular risk classification and modification strategies
• An association between dysregulation of glucose and lipid metabolism and the related risk of type 2 diabetes during treatment with any of the eight second-generation antipsychotics currently available in the United States
• Guidance in choice of medications and appropriate monitoring strategies for hyperlipidemia, along with recognition of which antipsychotics pose the greatest risk and an understanding of the common dyslipidemia patterns seen with their use

Chapters include key clinical concepts, quick-reference tables, and extensive references, and a final chapter provides an assessment tool for evaluating patients' metabolic risk. Together, the chapters in this book constitute an authoritative clinical guide that enables psychiatrists to better integrate the treatment of patients' mental disorders with their metabolic conditions.

Have suggestions for purchases? Contact Karen Grigg at grigg012@mc.duke.edu